Sanovas - About the company
Sanovas is a series A company based in San Rafael (United States), founded in 2009. It operates as a Platform of tools for interventional therapeutics and diagnostic applications in various specialties. Sanovas has raised $9.52M in funding. The company has 16 active competitors, including 4 funded and 6 that have exited. Its top competitors include companies like Pulmonx, Selio Medical and Novate Medical.
Company Details
Sanovas is a medical device company developing a platform of interventional surgical tools for use in various specialties. The company has received FDA 510(k) clearance to market its PulmoVia working channel. PulmoVia is disposable device a tool for diagnostic and therapeutic interventions in the lung. PulmoVia is used to introduce instruments to obtain tissue samples, retrieve foreign bodies, and initiate therapies within the lung while keeping their critical care patients breathing easily. The company is initially targeting the pulmonary market, which includes treatment of lung cancer, COPD, asthma and cystic fibrosis. Apart from this, Sanovas is also developing devices for interventional ENT, and interventional urology & gynaecology. Sanovas devices are being developed a few core platform tachnologies which include ViaTM Working Channels, VasZeppelinTM Smart Catheters, MicroCamTM Imaging Technologies, StablePathTM Catheter Anchoring Technology, PhysioSenseTM Physiologic Measurement Systems, CytoVasTM Tissue Collection Technology, and NanoVasTM Local Therapy Delivery Systems. As of August 2016, all Sanovas products are investigational medical devices except PulmoVia have not been FDA approved or cleared for use in the United States. Pulmo via is FDA 510(k) cleared.
- Website
- www.sanovas.com/
Key Metrics
Founded Year
2009
Location
San Rafael, United States
Stage
Series A
Total Funding
$9.52M in 3 rounds
Latest Funding Round
Ranked
8th among 16 active competitors
Employee Count
13 as on Sep 30, 2026
Legal entities associated with Sanovas
Sanovas is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Sanovas, Inc. CIN: 371646318 , United States, Active | - | 20 (As on Dec 31, 2017) | - |
Sign up to download Sanovas' company profile
Sanovas's funding and investors
Sanovas has raised a total funding of $9.52M over 3 rounds. Its first funding round was on Jul 21, 2011.
Here is the list of recent funding rounds of Sanovas:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 04, 2015 | 4054965 | Series A | 9554212 | 2726526 | 7681001 | 9175767 |
Sep 18, 2013 | 9310491 | Series A | 7907168 | 9760735 | 4868084 | 5336288 |
Jul 21, 2011 | 4732381 | Seed | 6831403 | 3339368 | 8277604 | 2733009 |
View details of Sanovas's funding rounds and investors
Sanovas' founders and board of directors
Founder? Claim ProfileSanovas' Board of Directors
Sanovas's board has 7 active members. Lawrence J. Gerrans, Ken Koen, Erhan Gundy, Bruce A. Nichols, Erhan Gunday, Larry Gerrans and Rob Georges are independent board members.Here is the list of Sanovas' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 16y 3m | |
kgjyilb | Independent board member | - | Current | 8y 9m |
hpinalu | Independent board member | - | Current | 3y 7m |
unmoczj | Independent board member | - | Current | 5y 7m |
ltjaygy | Independent board member | - | Current | 4y 9m |
hkzcqps | Independent board member | - | Current | 2y 7m |
joncf{a | Independent board member | - | Current | 2y 7m |
Sanovas' employee count trend
Sanovas has 13 employees as of Sep 26. Here is Sanovas's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sanovas's Competitors and alternates
Top competitors of Sanovas include Pulmonx, Selio Medical and Novate Medical. Here is the list of Top 10 competitors of Sanovas, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Pulmonx 1998, Redwood City (United States), Public | Developer of smart devices for treating pulmonary diseases | $281M | 67/100 | |
2nd | Selio Medical 2016, Dublin (Ireland), Series A | Developer of device to prevent pneumothorax during transthoracic needle biopsy | $5.81M | 52/100 | |
3rd | Novate Medical 2006, Galway (Ireland), Acquired | Provider of inferior vena cava filter for treatment of pulmonary embolism | $18M | 46/100 | |
4th | Spiration 1999, Redmond (United States), Acqui-Hired | Emphysema treatment using minimally invasive Spiration Valve System to improve life | $73.9M | 40/100 | |
5th | Uptake Medical 2005, Tustin (United States), Acquired | Medical device company improving lives through vapor ablation for pulmonary disease | $71.7M | 38/100 | |
6th | Range of product and therapy solutions for cardiac surgeons and perfusionists. | - | - | 37/100 | |
7th | PneumRx 2004, Mountain View (United States), Acquired | Medical solutions innovator dedicated to transforming lives through science | $49.6M | 33/100 | |
8th | Sanovas 2009, San Rafael (United States), Series A | Platform of tools for interventional therapeutics and diagnostic applications in various specialties | $9.52M | - | 32/100 |
9th | Emphasys Medical 2000, Redwood City (United States), Acqui-Hired | Developer of endobronchial valves for the treatment of emphysema | $68.4M | 32/100 | |
10th | Axess Vision Technology 2006, Corps (France), Acqui-Hired | Products for video-Bronchoscopy, video-Ureteroscopy and video-Cystoscopy | $4.82M | 32/100 |
Looking for more details on Sanovas's competitors? Click here to see the top ones
Sanovas's Investments and acquisitions
Sanovas has made no investments or acquisitions yet.
Reports related to Sanovas
Here is the latest report on Sanovas's sector:
News related to Sanovas
•
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of DirectorsGlobeNewswire•Jul 26, 2022•RetinalGeniX, Sanovas
•
Sanovas Inc Product Pipeline Analysis, 2017 Update Prices from USD $750Sectorpublishingintelligence•May 08, 2017•Sanovas
•
Sanovas Launches Infection Control Business To Address Expanding Global Threat Of Healthcare Acquired InfectionsBioSpace•Dec 14, 2016•Sanovas
•
•
•
•
•
Sanovas Fills Corporate Bench with Industry Veterans In Clinical, Regulatory and FinancePR Newswire•Nov 09, 2012•Sanovas
Are you a Founder ?
FAQs about Sanovas
Explore our recently published companies
- Homeschool Facts - Unfunded company
- Canbas Bio - Tangerang based, 2018 founded, Unfunded company
- BioNordika - Finland based, 1995 founded, Public company
- Shangkentech.com - 2018 founded, Unfunded company
- Innovsense.com - 2022 founded, Unfunded company
- Jupho - Mumbai based, Unfunded company